DOI:
10.1055/s-00000032
Klinische Neurophysiologie
LinksClose Window
References
Adams D, Gonzalez-Duarte A, O'Riordan WD. et al.
Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis.
N Engl J Med 2018;
379: 11-21
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.